Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Bloomberg outage, Chinese regulations send stocks into the red

Fri, 17th Apr 2015 12:02

After a solid start UK stocks sank into the red by Friday lunchtime, moving further away from recent records amid a blackout on Bloomberg computer terminals and new regulations in China on short-selling.Bloomberg's trading and information units are heavily relied upon by roughly 320,000 people around the world and were thought to be affecting trading volumes.Meanwhile, China on Friday allowed fund managers to lend stocks for short-selling to boost the supply of shares."The news from China and the continued Bloomberg issues added to the already perilous situation in Greece to create an unfriendly trading environment at the end of the week," said Spreadex analyst Connor Campbell.The FTSE 100, which rose to a high of 7,093.52 early on, was down 0.65% at 7,014.37 by midday. The index had set a new all-time closing high on Wednesday at 7,096.78.All eyes continue to be on Greece as its debt crisis dominates proceedings at the International Monetary Fund-World Bank spring meetings in Washington.Pierre Moscovici, European Commissioner for economic and financial affairs, said there is no Plan B for Greece regarding a deal over a rescue package. Meanwhile, IMF managing director Christine Lagarde denied speculation that the IMF was willing to grant a delay on the repayment of loans due next month.Yanis Varoufakis responded by saying that Greece will "compromise, compromise, compromise without 'being' compromised".Data meets forecastsIn economic data on Friday, the UK unemployment rate fell from 5.7% to 5.6% in the three months to February, its lowest since July 2008 and in line with expectations. Weekly annual earnings growth picked up more than expected from 1.6% to 1.8%.The final estimate of the Eurozone consumer price index (CPI) confirmed that prices fell at a year-on-year rate of 0.1% in March, in line with initial readings but easing from a 0.3% drop in February.US inflation figures out later on are expected to show that prices stagnated again in March, with the CPI remaining at zero.Rolls-Royce and Astrazeneca riseEngine maker Rolls-Royce was among the best performers after winning its largest-ever order, worth $9.2bn, to provide Trent 900 engines and TotalCare service support to Emirates.Astrazeneca edged higher after its eye cancer treatment, selumetinib, was given 'orphan drug' status by US regulators, which should smooth its path to full approval.GKN was trading in the red after Exane BNP Paribas downgraded the stock to 'neutral'.Engineering and consulting outfit Ricardo was in demand after expanding its rail services with the £42.5m acquisition of consultancy and assurance business Lloyd's Register Rail.Shares in Applied Graphene Materials jumped after the graphene products group reported positive results from independent coatings trials.Market MoverstechMARK 3,205.44 -0.48%FTSE 100 7,014.37 -0.65%FTSE 250 17,602.55 -0.72%FTSE 100 - RisersSevern Trent (SVT) 2,144.00p +1.08%BP (BP.) 476.75p +0.70%Rolls-Royce Holdings (RR.) 984.50p +0.46%Pearson (PSON) 1,375.00p +0.36%Ashtead Group (AHT) 1,118.00p +0.27%Persimmon (PSN) 1,735.00p +0.12%Whitbread (WTB) 5,230.00p +0.10%Randgold Resources Ltd. (RRS) 5,085.00p +0.10%Sky (SKY) 1,048.00p +0.10%London Stock Exchange Group (LSE) 2,533.00p +0.08%FTSE 100 - FallersHikma Pharmaceuticals (HIK) 2,068.00p -2.73%St James's Place (STJ) 938.50p -2.09%Tesco (TSCO) 236.10p -2.05%GKN (GKN) 364.00p -1.78%Hargreaves Lansdown (HL.) 1,215.00p -1.78%Barclays (BARC) 255.95p -1.69%Schroders (SDR) 3,286.00p -1.68%Aberdeen Asset Management (ADN) 482.20p -1.59%3i Group (III) 497.90p -1.50%International Consolidated Airlines Group SA (CDI) (IAG) 563.50p -1.49%FTSE 250 - RisersHunting (HTG) 630.00p +4.74%QinetiQ Group (QQ.) 204.00p +4.56%Debenhams (DEB) 87.95p +3.59%Zoopla Property Group (WI) (ZPLA) 197.90p +2.06%Laird (LRD) 352.50p +1.73%Pennon Group (PNN) 849.50p +1.68%WH Smith (SMWH) 1,407.00p +1.59%Playtech (PTEC) 786.50p +1.22%Soco International (SIA) 184.70p +1.15%Countrywide (CWD) 532.00p +1.14%FTSE 250 - FallersEvraz (EVR) 196.10p -4.53%Rotork (ROR) 2,536.00p -4.05%Indivior (INDV) 206.10p -3.38%Ocado Group (OCDO) 354.00p -3.28%Henderson Group (HGG) 286.10p -3.18%Allied Minds (ALM) 676.50p -3.01%NMC Health (NMC) 704.50p -2.96%Supergroup (SGP) 958.00p -2.94%FirstGroup (FGP) 100.40p -2.52%Kaz Minerals (KAZ) 235.70p -2.48%
More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.